A2A Adenosine Receptor Agonist for the Treatment of IBD

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$673,023.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43DK066880-01
Agency Tracking Number:
DK066880
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
ADENOSINE THERAPEUTICS, LLC
310 FOURTH STREET NE, SUITE 201, CHARLOTTESVILLE, VA, 22902
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
ROBERT Thompson
(434) 951-9484
RDT@ADENRX.COM
Business Contact:
ROBERT CAPON
(434) 220-9400
ROB@ADENRX.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Adenosine Therapeutics, LLC (ATL) is a biotechnology company started in Charlottesville, Virginia in 1999. ATL owns patents on the formulation and use of a family of potent and highly selective agonists of A2A adenosin

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government